Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on November 18, 2021. The filing serves to distribute a press release dated November 18, 2021, to U.S. investors pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, no data is available regarding revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. The substance of the report is contained in the attached press release (Exhibit 99.1), which is not included in the input text.
Guidance, Outlook, and Risks
Management commentary, future guidance, risk factors, and contingencies are not present in the provided text. The filing references a press release for these details but does not reproduce them.
Investor Verification Checklist
- Verify the full content of the press release dated November 18, 2021, referenced as Exhibit 99.1.
- Confirm the specific corporate event or announcement triggering this filing, as the cover page does not specify the subject matter.
- Review the company's most recent Form 20-F for the latest audited financial data, as this 6-K does not contain financial figures.